title: [How should one anticipate the assessment of the public health benefit of new medicines?].
authors.affiliation: Institut Phisquare, Fondation Transplantation, Besançon, France. jacques.massol@univ-fcomte.fr
authors.forename: Jacques
authors.initials: J
authors.lastname: Massol
authors.forename: Alain
authors.initials: A
authors.lastname: Puech
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Boissel
mesh_terms: D003256:Community Participation; D004345:Drug Industry; D004358:Drug Therapy / Q000191:economics / Q000592:standards* / Q000639:trends*; D005602:France; D006801:Humans; D011634:Public Health / Q000592:standards / Q000639:trends*; D012051:Reimbursement Mechanisms